South America Host Cell Protein Testing Market Size, Share, Trends & Forecast
south america host cell protein testing market was valued at USD 82.8 million in 2024 and is projected to reach USD 103.5 million by 2035, expanding at a CAGR of about 2.05% from 2025 to 2035. Increasing biopharmaceutical production, regulatory scrutiny, and biotechnology investment are supporting demand for host cell protein testing across the region.
Technological advancement is becoming an important market trend, with laboratories adopting high-throughput screening and advanced analytical techniques. These technologies can improve testing accuracy and efficiency while helping reduce turnaround times associated with biopharmaceutical development.
ELISA-based assays currently represent the dominant type segment because of their established methodologies and suitability for large-scale testing. PCR-based assays are identified as the fastest-growing category, supported by their sensitivity, rapid results, and increasing adoption of advanced testing approaches.
Biopharmaceutical companies account for the largest end-user segment, while contract research organizations are experiencing increasing demand as pharmaceutical companies outsource specialized testing activities. Growing biosimilar development and stricter quality requirements are also creating opportunities for testing service providers.
Understand industry shifts with well-researched analysis:
Single Use Bioprocessing Market Trends
Enteral Feeding Devices Market Growth
Structural Heart Devices Market Demand